Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Jun 13, 2005 by Edgar Snyder

FDA Issues Drug Mix-Up Warning

Toprol-XL / Topamax Mixup

Before you leave the pharmacy, make sure you have the correct prescription drug. That’s because the Food and Drug Administration (FDA) and drug manufacturer AstraZeneca issued warnings about mix-ups with three brand-name drugs.

AstraZeneca received reports of distribution errors involving their drug Toprol-XL, a beta-blocker used to treat heart failure and hypertension. Toprol-XL is confused with Johnson & Johnson’s Topamax, used to treat epilepsy and migraines, and Novartis’s Tegretol, used to treat seizures and neuralgia. The three drug names are so similar, verbal and written prescriptions are incorrectly interpreted and filled.

Some patients have been hospitalized with worsened underlying conditions, a result of incorrect medications. The mix-ups have caused patients to have seizures, hallucinations, hypertension, and even attempt suicide. So far, the FDA hasn’t reported the total number of mix-ups or patients who suffered adverse effects.

For more information about dangerous drugs, visit the Dangerous Drug and Recall Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “Agency Warns of Drug Mix-Ups.” By The Dow Jones Newswire. The Wall Street Journal. September 28, 2005.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers